🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Removal

According to the social media company, the platform has taken down violative content and prohibited associated keywords and search suggestions. The company said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, positive reviews and detailed guides for mixing or administering at home.

After minutes of joining one group, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, posts display black plastic parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service stated it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant medical dangers”.